Dr Shailendra Singh
Dr Shailendra Singh is the Founder and Chief Executive Officer of Cellomatics Biosciences, a Nottingham-based preclinical CRO specialising in human-relevant, cell-based translational models. He brings over 20 years of experience across academia, diagnostics, and the pharmaceutical and biotechnology sectors.
Originally trained as a medical doctor with a background in immunology, Dr Singh went on to complete a PhD in Molecular Medicine in the UK. He has held senior scientific roles in both academic and industrial environments, including Senior Discovery Scientist at hVIVO Services, supporting drug discovery programmes in inflammation and respiratory disease.
In 2015, Dr Singh founded Cellomatics with the vision of improving the predictability of preclinical research through advanced human cell models. Under his leadership, the company has grown into an internationally recognised CRO, achieving sustained double-digit growth, expanding into purpose-built laboratories, attaining ISO 9001:2015 certification, and supporting clients globally, including Europe and the United States.
Dr Singh has driven the development of primary human cell systems, immune co-cultures, iPSC-derived models, 3D platforms, and organoid-based assays, enabling clients to make faster, more confident development decisions. He is recognised for his collaborative, innovation-led leadership style and remains closely involved in scientific strategy and client engagement.